Rubric Capital Management (New York)’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.87M | Sell |
1,575,376
-105,714
| -6% | -$327K | 0.07% | 57 |
|
|
2025
Q1 | $5.87M | Hold |
1,681,090
| – | – | 0.11% | 56 |
|
|
2024
Q4 | $5.5M | Hold |
1,681,090
| – | – | 0.07% | 58 |
|
|
2024
Q3 | $6.47M | Hold |
1,681,090
| – | – | 0.11% | 54 |
|
|
2024
Q2 | $5.19M | Buy |
+1,681,090
| New | +$5.19M | 0.14% | 60 |
|
|
2023
Q3 | – | Sell |
-3,395,855
| Closed | -$7.81M | – | 60 |
|
|
2023
Q2 | $7.81M | Sell |
3,395,855
-799,217
| -19% | -$1.84M | 0.33% | 51 |
|
|
2023
Q1 | $12.7M | Buy |
4,195,072
+728,791
| +21% | +$2.21M | 0.33% | 50 |
|
|
2022
Q4 | $8.08M | Buy |
+3,466,281
| New | +$8.08M | 0.35% | 60 |
|